These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 11709352

  • 1. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Neuhauser MM, Prause JL, Danziger LH, Pendland SL.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3613-5. PubMed ID: 11709352
    [Abstract] [Full Text] [Related]

  • 2. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Berry V, Thorburn CE, Knott SJ, Woodnutt G.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
    [Abstract] [Full Text] [Related]

  • 3. In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
    Neuhauser MM, Prause JL, Danziger LH, Pendland SL.
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1132-4. PubMed ID: 12604554
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of the ketolide ABT-773.
    Barry AL, Fuchs PC, Brown SD.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A, Al-Zarouni M, Al-Najjar J, Nublusi A, Panigrahi D.
    J Infect Dev Ctries; 2007 Dec 01; 1(3):296-302. PubMed ID: 19734608
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
    Gómez-Lus ML, García Y, Valero E, Amores R, Fuentes F.
    Rev Esp Quimioter; 2000 Sep 01; 13(3):306-13. PubMed ID: 11086282
    [Abstract] [Full Text] [Related]

  • 10. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V, Hoover J, Singley C, Woodnutt G.
    Antimicrob Agents Chemother; 2005 Mar 01; 49(3):908-15. PubMed ID: 15728883
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections.
    Krishnan P, Rajendran P, Sambandan AP, Anitha C, Chavda RK, Khobragade KJ.
    J Indian Med Assoc; 2011 Apr 01; 109(4):241-2, 244. PubMed ID: 22187795
    [Abstract] [Full Text] [Related]

  • 12. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
    Credito KL, Lin G, Pankuch GA, Bajaksouzian S, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2001 Jan 01; 45(1):67-72. PubMed ID: 11120946
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain.
    Isla A, Trocóniz IF, Canut A, Labora A, Martín-Herrero JE, Pedraz JL, Gascón AR.
    Enferm Infecc Microbiol Clin; 2011 Mar 01; 29(3):167-73. PubMed ID: 21334779
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Brueggemann AB, Doern GV, Huynh HK, Wingert EM, Rhomberg PR.
    Antimicrob Agents Chemother; 2000 Feb 01; 44(2):447-9. PubMed ID: 10639382
    [Abstract] [Full Text] [Related]

  • 15. Exacerbation of COPD: amoxicillin + clavulanic acid in vitro activity vs S. pneumoniae, H. influenzae and M. catarrhalis.
    Beghi G, Legnani D, De Bartolo A, Pagani N, Lusco G.
    J Chemother; 1995 Nov 01; 7 Suppl 4():61-2. PubMed ID: 8904109
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004.
    Daoud Z, Cocozaki A, Hakime N.
    Clin Microbiol Infect; 2006 Jan 01; 12(1):86-90. PubMed ID: 16460553
    [Abstract] [Full Text] [Related]

  • 17. [The postantibiotic effect of amoxicillin/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity].
    García Y, Gómez MJ, Ramos MC, Gómez-Lus ML, Prieto J.
    Rev Esp Quimioter; 1998 Jun 01; 11(2):157-60. PubMed ID: 9795302
    [Abstract] [Full Text] [Related]

  • 18. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V, Bozdogan B, Jacobs MR, Ubukata K, Appelbaum PC.
    J Antimicrob Chemother; 2003 Dec 01; 52(6):1018-21. PubMed ID: 14585854
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec 01; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial effects of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae strains for which MICs are high, in an in vitro pharmacokinetic model.
    MacGowan AP, Noel AR, Rogers CA, Bowker KE.
    Antimicrob Agents Chemother; 2004 Jul 01; 48(7):2599-603. PubMed ID: 15215115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.